Melanocyte-stimulating hormone (MSH), also known as melanotropin, is a group of peptide hormones produced primarily by the pituitary gland, hypothalamus, and skin cells.
Its major role is stimulating the production and release of melanin in skin and hair, which provides protection against UV radiation.
Beyond pigmentation, MSH is a modulatory peptide involved in appetite suppression, energy balance, and immune system regulation.
MSH exists in three main forms—alpha-MSH, beta-MSH, and gamma-MSH—all of which are derived from a larger precursor protein called pro-opiomelanocortin (POMC).
alpha-MSH: The most potent form for skin pigmentation.
MSH primarily from the pituitary gland (intermediate and anterior lobes) and the arcuate nucleus of the hypothalamus.
It is also produced locally in the skin by keratinocytes and melanocytes.
MSH works by binding to melanocortin receptors (MCRs), which are spread throughout the body:
Skin Pigmentation (MC1R): Stimulates melanocytes to produce melanin, specifically eumelanin (dark pigment).
This process is often triggered by UV light exposure.
Appetite & Metabolism: In the brain, alpha-MSH acts as an anorexigenic peptide, meaning it suppresses appetite and increases energy expenditure.
Modulates the immune response by downregulating pro-inflammatory cytokines and may even have direct antimicrobial properties against certain bacteria and fungi.
Research suggests peripheral alpha-MSH can increase glucose uptake in skeletal muscles.
Clinical Significance
Excess MSH: Can cause hyperpigmentation.
This is often seen in Addison’s disease or Cushing’s disease because MSH and ACTH share the same precursor.
MSH Deficiency: Linked to increased food intake, obesity, and a lack of skin pigmentation, which increases the risk of UV-induced DNA damage.
Genetic Variants: Some people, particularly those with red hair and fair skin, have variants in their MC1R receptor that make them less responsive to MSH.
Synthetic versions of MSH, such as afamelanotide are used to treat conditions like erythropoietic protoporphyria.
, also known as melanotropin, is a group of peptide hormones produced primarily by the pituitary gland, hypothalamus, and skin cells.
Its major role is stimulating the production and release of melanin in skin and hair, which provides protection against UV radiation.
Beyond pigmentation, MSH is a modulatory peptide involved in appetite suppression, energy balance, and immune system regulation.
MSH exists in three main forms—alpha-MSH, beta-MSH, and gamma-MSH—all of which are derived from a larger precursor protein called pro-opiomelanocortin (POMC).
alpha-MSH: The most potent form for skin pigmentation.
MSH primarily from the pituitary gland (intermediate and anterior lobes) and the arcuate nucleus of the hypothalamus.
It is also produced locally in the skin by keratinocytes and melanocytes.
MSH works by binding to melanocortin receptors (MCRs), which are spread throughout the body:
Skin Pigmentation (MC1R): Stimulates melanocytes to produce melanin, specifically eumelanin (dark pigment).
This process is often triggered by UV light exposure.
Appetite & Metabolism: In the brain, alpha-MSH acts as an anorexigenic peptide, meaning it suppresses appetite and increases energy expenditure.
Modulates the immune response by downregulating pro-inflammatory cytokines and may even have direct antimicrobial properties against certain bacteria and fungi.
Research suggests peripheral alpha-MSH can increase glucose uptake in skeletal muscles.
Clinical Significance
Excess MSH: Can cause hyperpigmentation.
This is often seen in Addison’s disease or Cushing’s disease because MSH and ACTH share the same precursor.
MSH Deficiency: Linked to increased food intake, obesity, and a lack of skin pigmentation, which increases the risk of UV-induced DNA damage.
Genetic Variants: Some people, particularly those with red hair and fair skin, have variants in their MC1R receptor that make them less responsive to MSH.
Synthetic versions of MSH, such as afamelanotide are used to treat conditions like erythropoietic protoporphyria.
. .